Endogenous opiates and behavior: 2022

RJ Bodnar - Peptides, 2023 - Elsevier
This paper is the forty-fifth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Effects of prenatal opioid exposure on synaptic adaptations and behaviors across development

SC Simmons, GG Grecco, BK Atwood, FS Nugent - Neuropharmacology, 2023 - Elsevier
In this review, we focus on prenatal opioid exposure (POE) given the significant concern for
the mental health outcomes of children with parents affected by opioid use disorder (OUD) in …

Preclinical research in paclitaxel-induced neuropathic pain: a systematic review

C Bacalhau, JT Costa-Pereira… - Frontiers in Veterinary …, 2023 - frontiersin.org
Introduction Chemotherapy-induced peripheral neuropathy (CIPN) is a common
consequence of cancer treatment and pain is a frequent complaint of the patients. Paclitaxel …

Evidence for endogenous opioid dependence related to latent sensitization in a rat model of chronic inflammatory pain

JC Morales-Medina, N Pugliese, A Di Cerbo… - International Journal of …, 2023 - mdpi.com
Studies performed in a mouse model of chronic inflammatory pain induced by intraplantar
injection of complete Freund's adjuvant (CFA) have shown that constitutive activation of the …

Behavioral Effects of Opioid Analgesics in the Presence or Absence of Chronic Neuropathic Pain

G Burgess - 2024 - deepblue.lib.umich.edu
Chronic neuropathic pain affects~ 6.9-10% of the American population. Previous research
suggested that chronic pain conditions may increase the susceptibility to developing an …

Investigating the role of NLRP3 inflammasome in chemotherapy-induced peripheral neuropathy

UO Warncke - 2022 - scholarscompass.vcu.edu
Paclitaxel and oxaliplatin are commonly used antineoplastic drugs that cause chemotherapy-
induce peripheral neuropathy (CIPN) in up to 90% of patients. The sensory symptoms of …